These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3052064

  • 1. A controlled trial of stimulant medication in children with the fragile X syndrome.
    Hagerman RJ, Murphy MA, Wittenberger MD.
    Am J Med Genet; 1988; 30(1-2):377-92. PubMed ID: 3052064
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE, Christopher J, Huestis R, Smeltzer DJ.
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE.
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [Abstract] [Full Text] [Related]

  • 4. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG, Vernacotola S, Peruzzi L, Tabolacci E, Mila M, Militerni R, Musumeci S, Ramos FJ, Frontera M, Sorge G, Marzullo E, Romeo G, Vallee L, Veneselli E, Cocchi E, Garbarino E, Moscato U, Chiurazzi P, D'Iddio S, Calvani M, Neri G.
    Am J Med Genet A; 2008 Apr 01; 146A(7):803-12. PubMed ID: 18286595
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
    Elia J, Borcherding BG, Rapoport JL, Keysor CS.
    Psychiatry Res; 1991 Feb 01; 36(2):141-55. PubMed ID: 2017529
    [Abstract] [Full Text] [Related]

  • 7. The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports.
    Schmidt K, Solanto MV, Sanchez-Kappraff M, Vargas P, Wein S.
    J Clin Psychopharmacol; 1984 Apr 01; 4(2):100-3. PubMed ID: 6707235
    [Abstract] [Full Text] [Related]

  • 8. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S, Mohammadi MR, Khademi M.
    BMC Psychiatry; 2004 Apr 08; 4():9. PubMed ID: 15070418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB, Burkhart JE, Hersen M, Helsel WJ.
    J Am Acad Child Adolesc Psychiatry; 1989 Sep 08; 28(5):761-7. PubMed ID: 2676965
    [Abstract] [Full Text] [Related]

  • 13. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS.
    Clin Pharmacol Ther; 1990 Jul 08; 48(1):57-66. PubMed ID: 2196146
    [Abstract] [Full Text] [Related]

  • 14. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D, Jarman F, Barker M.
    Pediatrics; 1997 Dec 08; 100(6):E6. PubMed ID: 9382907
    [Abstract] [Full Text] [Related]

  • 15. Oral folic acid versus placebo in the treatment of males with the fragile X syndrome.
    Hagerman RJ, Jackson AW, Levitas A, Braden M, McBogg P, Kemper M, McGavran L, Berry R, Matus I, Hagerman PJ.
    Am J Med Genet; 1986 Dec 08; 23(1-2):241-62. PubMed ID: 3513567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE, Gadow KD, Sprafkin J.
    Pediatrics; 1999 Apr 08; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [Abstract] [Full Text] [Related]

  • 19. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD, Wolraich ML.
    Pediatr Clin North Am; 1989 Oct 08; 36(5):1183-97. PubMed ID: 2677938
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.